RT Journal Article
SR Electronic
T1 COVID-19-related disruptions to routine vaccination services in India: perspectives from pediatricians
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.25.21250040
DO 10.1101/2021.01.25.21250040
A1 Shet, Anita
A1 Dhaliwal, Baldeep
A1 Banerjee, Preetika
A1 Carr, Kelly
A1 DeLuca, Andrea
A1 Britto, Carl
A1 Seth, Rajeev
A1 Parekh, Bakul
A1 Basavaraj, GV
A1 Gupta, Piyush
A1 Shastri, Digant
YR 2021
UL http://medrxiv.org/content/early/2021/01/27/2021.01.25.21250040.abstract
AB Background and Objective The COVID-19 pandemic has led to disruptions to routine immunization programs in India and around the world, setting the stage for potentially serious outbreaks of vaccine-preventable diseases.Methods We surveyed pediatric healthcare providers in India in 2 rounds in April-June and September 2020 to understand how COVID-19 control measures may have impacted routine vaccination.Results Respondents were predominantly pediatricians working in primary, secondary or tertiary healthcare centers, across 21 Indian states and two union territories. Among the 424 (survey 1) and 141 (survey 2) respondents, 33.4% and 7.8%, respectively, reported near complete suspension of vaccination services due to COVID-19. A 50% or greater drop in vaccination services was reported by 83.1% of respondents in June, followed by 32.6% four months later, indicating slow recovery of services. By September 2020, 83.6% were aware of updated guidelines on safe provision of immunization services, although awareness of specific catch-up vaccination plans was low, and 76.6% expressed concern about a vaccine coverage gap that could potentially lead to increased non-COVID-19 illnesses and deaths.Conclusions Pandemic-related disruptions to vaccination services were reported by pediatricians across India. Concerted efforts are needed from governing and academic groups to ensure that routine immunization and catch-up programs are implemented during this pandemic, which can sustain gains in vaccination coverage and provide a robust blueprint for the national roll-out of the COVID-19 vaccine.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors gratefully acknowledge partial funding support from the Johns Hopkins Maternal and Child Health Center, India, as well as support from the Indian Academy of Pediatrics.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was reviewed by the Institutional Review Board of the Johns Hopkins School of Public Health and was determined to be exempt from human subjects research ethical oversight.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials. Derived data supporting the findings of this study are available from the corresponding author [AS] on request.